Literature DB >> 32944009

Preferred level of categorization as strategy to manage chronic illness-related identity among individuals with type 1 versus type 2 diabetes.

Kristi A Costabile1, Sarah E Boland2, Susan Persky2.   

Abstract

The present investigation examined social identification management among individuals affected by chronic illness. Because diabetes is a chronic medical condition that consists of a broad superordinate group with two nested subgroups of differing relative status (type 1 versus type 2), it is well-suited to an examination of positive identity management strategies used by individuals with chronic illness. A cross-sectional survey was conducted on individuals with diabetes (N = 399) to assess diabetes-related identity. Results indicated that individuals with type 1 diabetes reported greater identity centrality and greater preference for subgroup self-categorization ("individual affected by type 1 diabetes") over superordinate group categorization ("individual affected by diabetes") than did individuals with type 2 diabetes. The relationship between diabetes type and preferred categorization level was moderated by perceived intractability of their condition and perceived stigmatization of the lower status subgroup (i.e., type 2), suggesting that categorization level functions to maintain a positive self-concept. Further, categorization level moderated the negative relationship between identity centrality and feelings of depression and anger, suggesting that self-categorization might function to protect against self-concept threat. The present findings highlight the roles of group status, group boundary permeability, and perceived stigma on identity management strategies used by individuals with a chronic illness.

Entities:  

Keywords:  diabetes; illness; self-categorization; self-concept; social identity; stigma

Year:  2019        PMID: 32944009      PMCID: PMC7491865          DOI: 10.1080/15298868.2019.1662476

Source DB:  PubMed          Journal:  Self Identity        ISSN: 1529-8868


  37 in total

Review 1.  The influence of social support on chronic illness self-management: a review and directions for research.

Authors:  Mary P Gallant
Journal:  Health Educ Behav       Date:  2003-04

2.  Taking the strain: social identity, social support, and the experience of stress.

Authors:  S Alexander Haslam; Anne O'Brien; Jolanda Jetten; Karine Vormedal; Sally Penna
Journal:  Br J Soc Psychol       Date:  2005-09

3.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

4.  Nature, nurture, or that fast food hamburger: media framing of diabetes in the New York Times from 2000 to 2010.

Authors:  Kelsey Stefanik-Sidener
Journal:  Health Commun       Date:  2012-07-02

Review 5.  Type 1 diabetes: pathogenesis and prevention.

Authors:  Kathleen M Gillespie
Journal:  CMAJ       Date:  2006-07-18       Impact factor: 8.262

6.  Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group.

Authors: 
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

7.  Gender Differences in Emotion Regulation: An fMRI Study of Cognitive Reappraisal.

Authors:  Kateri McRae; Kevin N Ochsner; Iris B Mauss; John J D Gabrieli; James J Gross
Journal:  Group Process Intergroup Relat       Date:  2008-04

Review 8.  The association between Diabetes mellitus and Depression.

Authors:  S V Bădescu; C Tătaru; L Kobylinska; E L Georgescu; D M Zahiu; A M Zăgrean; L Zăgrean
Journal:  J Med Life       Date:  2016 Apr-Jun

9.  Stigma in People With Type 1 or Type 2 Diabetes.

Authors:  Nancy F Liu; Adam S Brown; Michael F Younge; Susan J Guzman; Kelly L Close; Richard Wood
Journal:  Clin Diabetes       Date:  2017-01

10.  'I call it the blame and shame disease': a qualitative study about perceptions of social stigma surrounding type 2 diabetes.

Authors:  Jessica L Browne; Adriana Ventura; Kylie Mosely; Jane Speight
Journal:  BMJ Open       Date:  2013-11-18       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.